Inventiva (IVA) Revenue (2019 - 2021)
Inventiva (IVA) posted quarterly Revenue of $78277.6 for Q2 2021, down 3.96% year-over-year from $81508.0 in Q2 2020, and down 12.31% quarter-over-quarter from $89261.5 in Q1 2021.
Inventiva (IVA) Revenue (2019 - 2021) Analysis & Trends
Inventiva's Revenue history runs 3 years deep, the most recent figure standing at $78277.6 for Q2 2021.
- In Q2 2021, Revenue fell 3.96% year-over-year to $78277.6; the TTM figure through Jun 2021 stood at $692579.0 (changed N/A YoY), while the FY2025 annual figure was $9.2 million, down 41.37% from the prior year.
- Revenue for Q2 2021 stood at $78277.6, down from $89261.5 in the prior quarter.
- The five-year high for Revenue was $7.7 million in Q4 2019, with the low at $78277.6 in Q2 2021.
- The 3-year median for Revenue is $92652.1 (2021), against an average of $1.4 million.
- The sharpest annual moves came in 2020 and 2021: Revenue tumbled 94.27% in 2020, then fell 3.96% in 2021.
- Inventiva's Revenue stood at $7.7 million in 2019, then sank by 94.27% to $443531.8 in 2020, then slumped by 82.35% to $78277.6 in 2021.
- Business Quant data shows IVA's Revenue at $78277.6 in Q2 2021, $89261.5 in Q1 2021, and $443531.8 in Q4 2020.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Revenue (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn | 3.33 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn | 4.29 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn | 1.56 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn | 1.71 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn | 3,001.92 |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - | 674.14 Mn |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn | 1.29 Bn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn | 425.49 Mn |
| 10 | Inventiva | 888.89 Mn | 888.89 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2021 | 78,277.64 |
| Mar 31, 2021 | 89,261.47 |
| Dec 31, 2020 | 443,531.82 |
| Jun 30, 2020 | 81,508.05 |
| Mar 31, 2020 | 96,042.70 |
| Dec 31, 2019 | 7.75 Mn |